Additionally, it has been shown that the bifunctional DNA glycosylase NEIL2, which is upregulated in the breast cancer cell line Hs578T, outcompetes APE1 at AP sites and sensitizes breast cancer cells to APOBEC3 deaminase-mediated mutations [25]. Here, NEIL2 is linked to breast carcinoma.